2025
Where Do Organ Donors Come From in the United States? An Analysis of Urban and Rural Donation
Shadid A, Chen C, Godfrey E, Xu A, Goss J, Rana A. Where Do Organ Donors Come From in the United States? An Analysis of Urban and Rural Donation. Clinical Transplantation 2025, 39: e70231. PMID: 40638396, PMCID: PMC12244443, DOI: 10.1111/ctr.70231.Peer-Reviewed Original ResearchConceptsRural-Urban Commuting AreaAnalysis of urbanizationMetropolitan coreZip codesRural-urbanResidential zip codeCDC WONDER databaseHealth Research CenterCommuting areaRuralDeceased donor allograftsUnited StatesWONDER databaseRural zonesMortality dataDonor supplyDonor organ supplyDonor allograftsPressor supportUrban zonesOrgan transplantationCriteria donorsMechanism of deathTransplant accessDonor pool
2022
Trends in Survival for Pediatric Transplantation.
Hickner B, Anand A, Godfrey E, Dunson J, Reul R, Cotton R, Galvan N, O'Mahony C, Goss J, Rana A. Trends in Survival for Pediatric Transplantation. 2022, 149 PMID: 35079811, DOI: 10.1542/peds.2020-049632.Peer-Reviewed Original ResearchConceptsTreat survivalKidney transplantPosttransplant survivalHeart transplantPediatric transplantationMultivariable Cox regressionPercentage of patientsKaplan-Meier methodLog-rank testLiver transplantPosttransplant outcomesTreat analysisTransplant ratesCox regressionDonor poolPatient's perspectiveTransplantPatient careStudy periodΧ2 testLiverSurvivalTransplantationSignificant increaseChildren
2021
Donor and Recipient Matching in Facial Vascularized Composite Allotransplantation: A Closer Look at the Donor Pool
Kauke M, Haug V, Obed D, Diehm Y, Tchiloemba B, Safi AF, Pomahac B. Donor and Recipient Matching in Facial Vascularized Composite Allotransplantation: A Closer Look at the Donor Pool. Plastic & Reconstructive Surgery 2021, 148: 194-202. PMID: 34181616, DOI: 10.1097/prs.0000000000008094.Peer-Reviewed Original ResearchConceptsDonor poolHepatitis CUnited NetworkPotential donorsEpstein-Barr virus seropositivityCytomegalovirus-seropositive donorsUnderrepresented patient groupsOrgan Sharing databaseFacial Vascularized Composite AllotransplantationHigh-risk characteristicsVascularized Composite AllotransplantationActual wait timesAllotransplant patientsSeronegative patientsSeropositive donorsMost patientsAllotransplant recipientsPatient characteristicsRecipient matchingSharing databasePositive donorsPatient groupVirus seropositivityOrgan SharingOrgan donors
2020
Ethical Implications of Donor Type for Uterus Transplantation: Why We Should Remain Wary of Using Living Donors.
Bruno B, Arora K. Ethical Implications of Donor Type for Uterus Transplantation: Why We Should Remain Wary of Using Living Donors. The Yale Journal Of Biology And Medicine 2020, 93: 587-592. PMID: 33005123, PMCID: PMC7513439.Peer-Reviewed Original Research
2019
Chapter 15 General Considerations and the Need for Liver Transplantation
Camarata M, Weiss K, Schilsky M. Chapter 15 General Considerations and the Need for Liver Transplantation. 2019, 173-182. DOI: 10.1016/b978-0-12-811077-5.00015-3.Peer-Reviewed Original ResearchAcute liver failureLiver transplantationWilson's diseaseLiver failureMedical therapyUse of LTEnd-stage liver diseaseLive donor transplantsOnly viable treatment optionViable treatment optionCombination of dietRare autosomal recessive disorderAlternative transplant strategyWilson's disease patientsAutosomal recessive disorderAuxiliary transplantInitial presentationLiver diseaseMedical managementNeurological symptomsTransplant strategiesTreatment optionsDisease patientsDonor poolDisease progression
2016
Potential Pediatric Organ Donors After Cardiac Death
Pregernig A, Karam O. Potential Pediatric Organ Donors After Cardiac Death. Transplantation Proceedings 2016, 48: 2588-2591. PMID: 27788786, DOI: 10.1016/j.transproceed.2016.06.049.Peer-Reviewed Original ResearchConceptsWithdrawal of careOrgan donorsAgonal timeMaximal resuscitationCardiac deathPediatric populationNeonatal intensive care unitOrgan donationBrain-dead childrenIntensive care unitOrgan donor poolTransplant waiting listPediatric organ donorPotential organ donorsOrgan donation programsMedical contraindicationsCare unitRetrospective studyDonor poolWaiting listDonation programDonor populationCareChildrenResuscitationWhat Every Hepatologist Should Know about Liver Transplantation
Yoo P, Mulligan D. What Every Hepatologist Should Know about Liver Transplantation. 2016, 608-616. DOI: 10.1002/9781119127437.ch93.Peer-Reviewed Original ResearchLiver transplantationPiggyback techniqueExcellent long-term patient outcomesLong-term patient outcomesHepatic venous complicationsRetrohepatic vena cavaDonor liver transplantationLiver transplant patientsRisk of complicationsBiliary complicationsSplit liverTransplant patientsTransplant recipientsVenous complicationsDonor transplantsMultidisciplinary careVena cavaDonor poolPatient outcomesTransplant operationSurgical techniqueOrgan allocationPhysiologic circumstancesComplicationsSuccessful outcome
2010
What Hepatologists Should Know about Liver Transplant Surgery
Mekeel K, Mulligan D. What Hepatologists Should Know about Liver Transplant Surgery. 2010, 305-316. DOI: 10.1002/9781444325249.ch30.Peer-Reviewed Original ResearchLiver transplantationExcellent long-term patient outcomesLong-term patient outcomesDonor liver transplantationLiver transplant surgeryBiliary complicationsDonor allograftsMultidisciplinary careSurgical outcomesTransplant surgeryDonor poolPatient outcomesTransplant operationHepatic anatomyPhysiologic eventsHepatologistsComplicationsPatientsTransplantationOutcomesAllograftsSurgeryHepatectomyDiagnosisCareHematopoietic Stem Cell Transplantation for Hemoglobinopathies: Current Practice and Emerging Trends
Smiers F, Krishnamurti L, Lucarelli G. Hematopoietic Stem Cell Transplantation for Hemoglobinopathies: Current Practice and Emerging Trends. Pediatric Clinics Of North America 2010, 57: 181-205. PMID: 20307718, DOI: 10.1016/j.pcl.2010.01.003.Peer-Reviewed Original ResearchConceptsHematopoietic stem cell transplantationStem cell transplantationCell transplantationNew conditioning regimensTreatment-related toxicityOnly curative optionNumber of patientsManagement of thalassemiaSickle cell diseaseConditioning regimensCurative optionTreatment complicationsDonor poolCell diseasePatientsLife expectancyTransplantationHemoglobinopathiesCurrent practiceRegimensComplications
2003
Recent Advances in Liver Transplantation
Wiesner RH, Rakela J, Ishitani MB, Mulligan DC, Spivey JR, Steers JL, Krom RA. Recent Advances in Liver Transplantation. Mayo Clinic Proceedings 2003, 78: 197-210. PMID: 12583530, DOI: 10.4065/78.2.197.Peer-Reviewed Original ResearchConceptsLiver transplantationHepatitis CEnd-stage liver disease (MELD) allocation systemRecurrent hepatitis C.Acute cellular rejectionDonor liver transplantationRecurrent hepatitis CDeath of patientsLong-term survivalLiver allocation policyQuality of lifeCellular rejectionChronic rejectionDomino transplantationImmunosuppressive regimensMetabolic complicationsRecurrent diseaseHepatitis C.Marginal donorsProlong survivalUnited NetworkHepatic support systemDonor poolEffective therapyDonor organsThermal homeostasis and liver transplantation.
D'Amico D, Vitale A, Cillo U, Boccagni P, Brolese A, Zanus G, Bassanello M, Montin U, Gringeri E, D'Amico F, Ciarleglio F, Cappuzzo G, Carraro A. Thermal homeostasis and liver transplantation. Acta BioMedica 2003, 74 Suppl 2: 30-3. PMID: 15055030.Peer-Reviewed Original ResearchConceptsGraft ischemia-reperfusion injuryGraft function recoveryPostoperative graft functionIschemia-reperfusion injuryInfluence of hypothermiaIntraoperative heat lossGraft functionLiver transplantationSevere hypothermiaCoagulation systemNormothermic oxygenated perfusionFunctional recoveryExtracorporeal circuitDonor poolAngiogenic mechanismsHypothermiaActive warmingOxygenated perfusionThermal homeostasisClinical researchGraftCardiovascular activityLiverDeleterious effectsHomeostasis
1990
Blood and Plasma Donations Among a Cohort of Intravenous Drug Users
Nelson K, Vlahov D, Margolick J, Bernal M, Taylor E. Blood and Plasma Donations Among a Cohort of Intravenous Drug Users. JAMA 1990, 263: 2194-2197. PMID: 1969502, DOI: 10.1001/jama.1990.03440160056037.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHIV-1 seroprevalenceIntravenous drug useDrug usersHuman immunodeficiency virus serologic statusDrug useHIV test resultsCD4 lymphocytesEntire cohortPeripheral bloodSerologic statusDonor poolIntravenous drugsHIV-1Blood donationMost subjectsPlasma donationBloodCohortDonation historySeroprevalenceDonationLymphocytesHistoryPlasma
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply